Improving healing after ACL surgery with targeted medicine
Localized small molecule delivery to improve tendon-to-bone integration following anterior cruciate ligament reconstruction
This work explores how a special medicine delivered directly to the knee might help tendons heal better to bone after ACL reconstruction surgery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11178693 on NIH RePORTER |
What this research studies
ACL injuries are very common and often require surgery where a new tendon is used to replace the torn ligament. Unfortunately, sometimes the new tendon doesn't heal perfectly to the bone, leading to complications like re-injury or instability. Our goal is to find a way to encourage stronger, more natural healing where the tendon meets the bone. We are focusing on a natural pathway in the body that helps build strong connections between tendons and bones during development, and we believe we can activate this pathway after surgery to improve recovery.
Who could benefit from this research
Good fit: This research is ultimately aimed at adults who undergo anterior cruciate ligament reconstruction surgery due to an ACL tear or rupture.
Not a fit: Patients who have not had or are not planning to have ACL reconstruction surgery would not directly benefit from this specific treatment approach.
Why it matters
Potential benefit: If successful, this approach could lead to stronger, more stable knee joints after ACL reconstruction, helping patients return to their active lives with less risk of re-injury.
How similar studies have performed: While the specific localized delivery of this small molecule for ACL healing is novel, our group's prior work has shown the importance of this biological pathway in forming strong tendon-to-bone connections.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Dyment, Nathaniel a. — University of Pennsylvania
- Study coordinator: Dyment, Nathaniel a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.